MEDBX | MEDFX | MEDBX / MEDFX | |
Total Expense Ratio | 1.81 | 1.06 | 171% |
Annual Report Gross Expense Ratio | 1.82 | 1.07 | 170% |
Fund Existence | 23 years | 16 years | - |
Gain YTD | 1.000 | 1.251 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7B | 7B | 100% |
Annual Yield % from dividends | 5.77 | 6.53 | 88% |
Returns for 1 year | 5.61 | 6.40 | 88% |
Returns for 3 years | 15.99 | 18.64 | 86% |
Returns for 5 years | 10.61 | 14.81 | 72% |
Returns for 10 years | 21.10 | 30.57 | 69% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FSIRX | 8.51 | N/A | N/A |
Fidelity Advisor Strategic Real Ret I | |||
GLCRX | 26.01 | N/A | N/A |
Goldman Sachs Large Cap Gr Insghts R | |||
UBPIX | 14.41 | N/A | N/A |
ProFunds UltraLatin America Inv | |||
MEMLX | 13.82 | N/A | N/A |
Morgan Stanley Inst EMkts Ldrs C | |||
INGFX | 33.94 | N/A | N/A |
Invesco Oppenheimer International Gr R5 |